TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
AORT

Artivion Inc

Healthcare · Medical Devices

24.10$ +2.1% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Income Statement

Artivion Inc (AORT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 441 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement AORT
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
37 51 61 67 77 88 78 60 62 69 81 95 105 112 117 120 132 141 145 146 180 190 263 276 253 299 314 354 389 441
11 15 22 27 30 37 66 31 38 32 37 36 37 42 48 44 47 50 53 55 61 61 90 93 85 101 111 125 140 171
26 36 39 40 47 51 12 28 25 37 44 59 68 70 68 76 85 90 91 91 119 129 173 183 168 198 203 229 249 270
2.8 3.9 4.7 4.4 5.2 4.7 4.6 3.6 3.9 3.7 3.5 4.5 5.3 5.2 5.9 6.9 7.3 8.5 8.7 10 13 19 23 23 24 36 39 29 28 31
16 21 24 25 29 34 48 54 43 53 42 46 49 50 49 57 65 67 73 75 92 101 141 143 140 169 165 184 191 226
20 27 32 32 37 39 52 57 47 57 45 51 54 55 55 64 72 77 82 85 105 121 164 166 165 189 196 223 210 244
5.9 8.7 6.8 7.5 9.8 12 -40 -29 -22 -20 -1.2 8.3 14 14 9.9 12 13 14 8.8 5.4 22 8.0 9.3 17 2.4 8.1 6.2 5.7 39 27
0.2 0.3 0.7 0.7 0.3 0.1 0.2 0.1 0.2 0.1 0.2 0.1 3.0 4.9 16 15 17 17 18 25 34 27
6.1 7.6 8.7 6.5 12 13 -41 -29 -22 -20 0.7 7.6 14 14 7.3 11 12 23 8.7 5.9 18 3.6 -6.4 1.6 -17 -15 -15 -22 -7.5 15
2.2 2.9 2.2 2.1 3.8 4.3 -14 3.1 -3.0 -0.4 0.3 0.4 -19 5.7 3.3 4.1 4.1 7.1 1.4 1.9 7.6 -0.1 -2.6 -0.1 -0.5 0.0 4.2 9.1 5.8 5.0
3.9 4.7 6.5 4.5 7.8 9.2 -28 -32 -19 -20 0.4 7.2 33 8.7 3.9 7.4 7.9 16 7.3 4.0 11 3.7 -3.8 1.7 -17 -15 -19 -31 -13 9.8
7.1 11 10 11 13 17 -35 -24 -16 -15 3.6 13 18 19 11 17 18 20 15 11 25 18 30 35 20 26 26 27 51 64

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?